B. Janetzky

发表

Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?

K. Jellinger, J. Attems, B. Janetzky, 2008, Journal of cellular and molecular medicine.

Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential

H. Reichmann, R. Funk, B. Janetzky, 2003, BioFactors.

Chemical Modification of the Mitochondrial Complex I Inhibitor 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline: Synthesis and Evaluation of N-Alkanoyl Derivatives

H. Reichmann, D. Feineis, G. Bringmann, 2000 .

Bromal-derived tetrahydro-beta-carbolines as neurotoxic agents: chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration.

H. Reichmann, D. Feineis, G. Bringmann, 2000, Bioorganic & medicinal chemistry.

Effect of highly halogenated β‐carbolines on dopaminergic cells in culture and on mitochondrial respiration

H. Reichmann, G. Bringmann, B. Janetzky, 1999 .

Data protection in biomaterial banks for Parkinson's disease research: The model of GEPARD (Gene bank Parkinson's Disease Germany)

W. Oertel, L. Schöls, T. Gasser, 2007, Movement disorders : official journal of the Movement Disorder Society.

Mitochondrial Disturbances in Parkinson’s Disease

H. Reichmann, P. Riederer, B. Janetzky, 1994 .

Sequence analysis of the entire mitochondrial genome in Parkinson's disease.

M. Beal, Michael T. Lin, A. Andreu, 2002, Biochemical and biophysical research communications.

The yeast WBP1 is essential for oligosaccharyl transferase activity in vivo and in vitro.

M. Aebi, B. Janetzky, L. Lehle, 1992, The EMBO journal.

Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia

H. Reichmann, M. Naumann, B. Janetzky, 1994, Movement disorders : official journal of the Movement Disorder Society.

Protection of dopaminergic neurons in primary culture by lisuride

H. Reichmann, B. Janetzky, W. Rausch, 2002, Journal of Neural Transmission.

Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.

H. Reichmann, P. Riederer, B. Janetzky, 1994, European journal of pharmacology.

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

K. Jellinger, H. Reichmann, P. Riederer, 1994, Neuroscience Letters.

Altered redox state of platelet coenzyme Q10 in Parkinson's disease

P. Riederer, M. Gerlach, W. Kuhn, 2000, Journal of Neural Transmission.

Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link?

H. Reichmann, P. Riederer, M. Gerlach, 2001, Alcoholism, clinical and experimental research.

Pergolide protects dopaminergic neurons in primary culture under stress conditions

H. Reichmann, H. Hundemer, B. Janetzky, 2002, Journal of Neural Transmission.

Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin

A. Kupsch, H. Reichmann, P. Riederer, 1996, Neurochemistry International.

Is the Point Mutation in Codon 331 of the Mitochondrial ND2 Gene Associated with Alzheimer’s Disease?

H. Reichmann, P. Riederer, B. Janetzky, 1995 .

Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage

B. Janetzky, W. Andler, P. Niklowitz, 2007, International journal of biological sciences.

A broader horizon of Alzheimer pathogenesis: ALZAS--an early serum biomarker?

K. Jellinger, B. Janetzky, E. Kienzl, 2002, Journal of neural transmission. Supplementum.

Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome.

H. Reichmann, L. Schöls, H. Przuntek, 1994, European neurology.

Alternatives to the suspended Alzheimer’s disease vaccine

K. Jellinger, B. Janetzky, E. Kienzl, 2002, Acta Neuropathologica.

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

K. Jellinger, L. Iversen, K. Lesch, 1995, Journal of Neural Transmission / General Section JNT.

TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain.

H. Reichmann, D. Feineis, G. Bringmann, 1995, Journal of neural transmission. Supplementum.

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I.

H. Reichmann, G. Bringmann, B. Janetzky, 1995, Journal of neural transmission. Supplementum.

Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y.

H. Reichmann, B. Janetzky, A. Constantinescu, 2007, Journal of neural transmission. Supplementum.

Ty4, a new retrotransposon from Saccharomyces cerevisiae, flanked by tau-elements.

B. Janetzky, L. Lehle, 1992, The Journal of biological chemistry.

Das mitochondriale Genom

H. Reichmann, B. Janetzky, P. Seibel, 1996 .

[Leptospirosis in wild animals].

B. Janetzky, F. Horsch, H. Drechsler, 1970, Monatshefte fur Veterinarmedizin.

Increased hippocampal DNA oxidation in serotonin transporter deficient mice

P. Riederer, K. Lesch, P. Riederer, 2002, Journal of Neural Transmission.

Dopamine and Glutamate in Parkinson’s Disease

H. Reichmann, P. Riederer, B. Janetzky, 2005 .

Highly Halogenated Tetrahydro-β-Carbolines as a New Class of Dopaminergic Neurotoxins

H. Reichmann, P. Riederer, D. Feineis, 1998 .

The Saccharomyces cerevisiae TRG1 gene is essential for growth and encodes a lumenal endoplasmic reticulum glycoprotein involved in the maturation of vacuolar carboxypeptidase.

H. Küntzel, B. Janetzky, L. Lehle, 1991, The Journal of biological chemistry.

Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients

W. Oertel, P. Bauer, L. Schöls, 2005, Movement disorders : official journal of the Movement Disorder Society.

Mitochondrial dysfunction – a pathogenetic factor in Parkinson’s disease

H. Reichmann, B. Janetzky, 2000, Journal of Neurology.

The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease

T. Klockgether, J. C. Möller, S. Paus, 2008, Movement disorders : official journal of the Movement Disorder Society.

Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany)

U. Steuerwald, B. Janetzky, J. Sander, 2001, European Journal of Pediatrics.

Neural degeneration in Parkinson's disease.

K. Lesch, H. Reichmann, K. Lange, 2001, Advances in neurology.

Novel mitochondrial DNA mutations in Parkinson's disease

H. Reichmann, T. Grünewald, B. Janetzky, 2002, Journal of Neural Transmission.

Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases.

H. Reichmann, L. Frölich, P. Riederer, 1996, European neurology.

The unique nested gene ALZAS as a potential source of Aβ-peptides in Alzheimer’s disease

H. Reichmann, B. Janetzky, Christin Gano, 2018, bioRxiv.

Progressive Neurodegeneration of the Dopaminergic system and Inhibition of the Complex I Induced by the Chloral-Derived Tetrahydro-β-Carboline TaClo

H. Reichmann, P. Riederer, T. Sontag, 1996 .

The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease

T. Klockgether, J. C. Möller, S. Paus, 2008, Movement disorders : official journal of the Movement Disorder Society.

Neurotoxic effects on the dopaminergic system induced by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline), a potential mammalian alkaloid : in vivo and in vitro studies

H. Reichmann, P. Riederer, T. Sontag, 1996 .